In 1872, Moritz Kaposi, a Hungarian dermatologist, describedfive men with aggressive "idiopathic multiple pigmented sarcomasof the skin."1 One patient died of gastrointestinal bleeding15 months after the initial appearance of the skin lesions,and an autopsy showed visceral lesions in the lungs and thegastrointestinal tract. Subsequently, other investigators describedfour clinical variants of Kaposi's sarcoma that had identicalhistologic features but developed in specific populations andhad different sites of involvement and rates of progression(Table 1). In the light of recent discoveries regarding theviral pathogenesis of Kaposi's sarcoma, these variants mostlikely represent . . . [Full Text of this Article]
Clinical Variants of Kaposi's Sarcoma
Classic Kaposi's Sarcoma
Endemic Kaposi's Sarcoma
Immunosuppression-Associated, or Transplantation-Associated, Kaposi's Sarcoma
Epidemic, or AIDS-Associated, Kaposi's Sarcoma
Kaposi's SarcomaAssociated Herpesvirus
Epidemiology of Kaposi's Sarcoma and KSHV
KSHV Infection in Humans
Rates of Infection in Various Populations
Transmission
Natural History of KSHV Infection
Treatment
Classic Kaposi's Sarcoma
Radiation Therapy
Systemic or Combination Therapy
Endemic Kaposi's Sarcoma
Immunosuppression-Associated Kaposi's Sarcoma
Epidemic Kaposi's Sarcoma
Radiation Therapy
Cytotoxic Drugs
Biologic Agents
Interferon in Combination with Antiretroviral Therapy
Experimental Therapies
Prevention
Source Information
From the Departments of Medicine (K.A.) and Pathology (Y.C.), Columbia University College of Physicians and Surgeons, New York.
Address reprint requests to Dr. Chang at P&S14-442, Department of Pathology, Columbia University College of Physicians and Surgeons, 630 W. 168th St., New York, NY 10032.
References
Related Letters:
Kaposi's Sarcoma
Washenik K., Clark-Loeser L., Friedman-Kien A., Simonart T., Vooren J.-P. V., Meuris S., Mazzone A., Ottini E., Paulli M., Antman K., Chang Y.
Extract |
Full Text
N Engl J Med 2000;
343:581-584, Aug 24, 2000.
Correspondence
This article has been cited by other articles:
Morris, V. A., Punjabi, A. S., Lagunoff, M.
(2008). Activation of Akt through gp130 Receptor Signaling Is Required for Kaposi's Sarcoma-Associated Herpesvirus-Induced Lymphatic Reprogramming of Endothelial Cells. J. Virol.
82: 8771-8779
[Abstract][Full Text]
(2008). Cutaneous Tumors, Massive Lymphadenopathy, and Secondary Lymphedema in a 16-Year-Old Boy--Diagnosis. Arch Dermatol
144: 1217-1222
[Full Text]
Subramanian, R., D'Auvergne, O., Kong, H., Kousoulas, K. G.
(2008). The Cytoplasmic Terminus of Kaposi's Sarcoma-Associated Herpesvirus Glycoprotein B Is Not Essential for Virion Egress and Infectivity. J. Virol.
82: 7144-7154
[Abstract][Full Text]
Wang, Y., Li, H., Tang, Q., Maul, G. G., Yuan, Y.
(2008). Kaposi's Sarcoma-Associated Herpesvirus ori-Lyt-Dependent DNA Replication: Involvement of Host Cellular Factors. J. Virol.
82: 2867-2882
[Abstract][Full Text]
Garrigues, H. J., Rubinchikova, Y. E., DiPersio, C. M., Rose, T. M.
(2008). Integrin {alpha}V 3 Binds to the RGD Motif of Glycoprotein B of Kaposi's Sarcoma-Associated Herpesvirus and Functions as an RGD-Dependent Entry Receptor. J. Virol.
82: 1570-1580
[Abstract][Full Text]
Makombe, S. D, Harries, A. D, Kwong-Leung Yu, J., Hochgesang, M., Mhango, E., Weigel, R., Pasulani, O., Fitzgerald, M., Schouten, E. J, Libamba, E.
(2008). Outcomes of patients with Kaposi's sarcoma who start antiretroviral therapy under routine programme conditions in Malawi. Trop Doct
38: 5-7
[Abstract][Full Text]
Burns, J., Shaknovich, R., Lau, J., Haramati, L. B.
(2007). Oncogenic Viruses in AIDS: Mechanisms of Disease and Intrathoracic Manifestations. Am. J. Roentgenol.
189: 1082-1087
[Abstract][Full Text]
Nun, T. K., Kroll, D. J., Oberlies, N. H., Soejarto, D. D., Case, R. J., Piskaut, P., Matainaho, T., Hilscher, C., Wang, L., Dittmer, D. P., Gao, S.-J., Damania, B.
(2007). Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma associated herpesvirus. Molecular Cancer Therapeutics
6: 2360-2370
[Abstract][Full Text]
Bihl, F., Narayan, M., Chisholm, J. V. III, Henry, L. M., Suscovich, T. J., Brown, E. E., Welzel, T. M., Kaufmann, D. E., Zaman, T. M., Dollard, S., Martin, J. N., Wang, F., Scadden, D. T., Kaye, K. M., Brander, C.
(2007). Lytic and Latent Antigens of the Human Gammaherpesviruses Kaposi's Sarcoma-Associated Herpesvirus and Epstein-Barr Virus Induce T-Cell Responses with Similar Functional Properties and Memory Phenotypes. J. Virol.
81: 4904-4908
[Abstract][Full Text]
Fuse, S., Bellfy, S., Yagita, H., Usherwood, E. J.
(2007). CD8+ T Cell Dysfunction and Increase in Murine Gammaherpesvirus Latent Viral Burden in the Absence of 4-1BB Ligand. J. Immunol.
178: 5227-5236
[Abstract][Full Text]
MOHANNA, S., MACO, V., GOWN, A., MORALES, D., BRAVO, F., GOTUZZO, E.
(2006). Is classic kaposi's sarcoma endemic in peru?: report of a case in an indigenous patient.. Am J Trop Med Hyg
75: 324-326
[Abstract][Full Text]
Wu, W., Vieira, J., Fiore, N., Banerjee, P., Sieburg, M., Rochford, R., Harrington, W. Jr, Feuer, G.
(2006). KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo. Blood
108: 141-151
[Abstract][Full Text]
Little, R. F., Pluda, J. M., Wyvill, K. M., Rodriguez-Chavez, I. R., Tosato, G., Catanzaro, A. T., Steinberg, S. M., Yarchoan, R.
(2006). Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma. Blood
107: 4650-4657
[Abstract][Full Text]
de Graaff, A. E., Weening, J. J., Krediet, R. T.
(2005). Massive oedema in a Cape Verde sailor. Nephrol Dial Transplant
20: 2545-2547
[Full Text]
Stratigos, A. J., Malanos, D., Touloumi, G., Antoniou, A., Potouridou, I., Polydorou, D., Katsambas, A. D., Whitby, D., Mueller, N., Stratigos, J. D., Hatzakis, A.
(2005). Association of Clinical Progression in Classic Kaposi's Sarcoma With Reduction of Peripheral B Lymphocytes and Partial Increase in Serum Immune Activation Markers. Arch Dermatol
141: 1421-1426
[Abstract][Full Text]
Caselli, E., Galvan, M., Cassai, E., Caruso, A., Sighinolfi, L., Di Luca, D.
(2005). Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reactivation in latently infected cells. Blood
106: 2790-2797
[Abstract][Full Text]
(2005). Purple Polypoid Masses on the Legs--Diagnosis. Arch Dermatol
141: 1311-1316
[Full Text]
Fuji, R. N., Patton, K. M., Steinbach, T. J., Schulman, F. Y., Bradley, G. A., Brown, T. T., Wilson, E. A., Summers, B. A.
(2005). Feline Systemic Reactive Angioendotheliomatosis: Eight Cases and Literature Review. Vet Pathol
42: 608-617
[Abstract][Full Text]
Sharma-Walia, N., Krishnan, H. H., Naranatt, P. P., Zeng, L., Smith, M. S., Chandran, B.
(2005). ERK1/2 and MEK1/2 Induced by Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Early during Infection of Target Cells Are Essential for Expression of Viral Genes and for Establishment of Infection. J. Virol.
79: 10308-10329
[Abstract][Full Text]
Zhang, X., Wang, J. F., Chandran, B., Persaud, K., Pytowski, B., Fingeroth, J., Groopman, J. E.
(2005). Kaposi's Sarcoma-associated Herpesvirus Activation of Vascular Endothelial Growth Factor Receptor 3 Alters Endothelial Function and Enhances Infection. J. Biol. Chem.
280: 26216-26224
[Abstract][Full Text]
Gentile, G., Capobianchi, A., Volpi, A., Palu, G., Pica, F., Calistri, A., Biasolo, M. A., Martino, P.
(2005). Human Herpesvirus 8 DNA in Serum During Seroconversion in Allogeneic Bone Marrow Transplant Recipients. JNCI J Natl Cancer Inst
97: 1008-1011
[Abstract][Full Text]
Sugaya, M., Watanabe, T., Yang, A., Starost, M. F., Kobayashi, H., Atkins, A. M., Borris, D. L., Hanan, E. A., Schimel, D., Bryant, M. A., Roberts, N., Skobe, M., Staskus, K. A., Kaldis, P., Blauvelt, A.
(2005). Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter. Blood
105: 2356-2363
[Abstract][Full Text]
Moosa, M.R.
(2005). Kaposi's sarcoma in kidney transplant recipients: a 23-year experience. QJM
98: 205-214
[Abstract][Full Text]
(2005). Multiple Violaceous Papules at an Amputation Site--Diagnosis. Arch Dermatol
141: 263-268
[Full Text]
Naranatt, P. P., Krishnan, H. H., Smith, M. S., Chandran, B.
(2005). Kaposi's Sarcoma-Associated Herpesvirus Modulates Microtubule Dynamics via RhoA-GTP-Diaphanous 2 Signaling and Utilizes the Dynein Motors To Deliver Its DNA to the Nucleus. J. Virol.
79: 1191-1206
[Abstract][Full Text]
Coras, B., Hafner, C., Reichle, A., Hohenleutner, U., Szeimies, R.-M., Landthaler, M., Vogt, T.
(2004). Antiangiogenic Therapy With Pioglitazone, Rofecoxib, and Trofosfamide in a Patient With Endemic Kaposi Sarcoma. Arch Dermatol
140: 1504-1507
[Abstract][Full Text]
Martro, E., Cannon, M. J., Dollard, S. C., Spira, T. J., Laney, A. S., Ou, C.-Y., Pellett, P. E.
(2004). Evidence for both Lytic Replication and Tightly Regulated Human Herpesvirus 8 Latency in Circulating Mononuclear Cells, with Virus Loads Frequently below Common Thresholds of Detection. J. Virol.
78: 11707-11714
[Abstract][Full Text]
Deutsch, E., Cohen, A., Kazimirsky, G., Dovrat, S., Rubinfeld, H., Brodie, C., Sarid, R.
(2004). Role of Protein Kinase C {delta} in Reactivation of Kaposi's Sarcoma-Associated Herpesvirus. J. Virol.
78: 10187-10192
[Abstract][Full Text]
Staudt, M. R., Kanan, Y., Jeong, J. H., Papin, J. F., Hines-Boykin, R., Dittmer, D. P.
(2004). The Tumor Microenvironment Controls Primary Effusion Lymphoma Growth in Vivo. Cancer Res.
64: 4790-4799
[Abstract][Full Text]
Luna, R. E., Zhou, F., Baghian, A., Chouljenko, V., Forghani, B., Gao, S.-J., Kousoulas, K. G.
(2004). Kaposi's Sarcoma-Associated Herpesvirus Glycoprotein K8.1 Is Dispensable for Virus Entry. J. Virol.
78: 6389-6398
[Abstract][Full Text]
Sergerie, Y., Abed, Y., Roy, J., Boivin, G.
(2004). Comparative Evaluation of Three Serological Methods for Detection of Human Herpesvirus 8-Specific Antibodies in Canadian Allogeneic Stem Cell Transplant Recipients. J. Clin. Microbiol.
42: 2663-2667
[Abstract][Full Text]
Cooray, S.
(2004). The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival. J. Gen. Virol.
85: 1065-1076
[Abstract][Full Text]
Sharma-Walia, N., Naranatt, P. P., Krishnan, H. H., Zeng, L., Chandran, B.
(2004). Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 Envelope Glycoprotein gB Induces the Integrin-Dependent Focal Adhesion Kinase-Src-Phosphatidylinositol 3-Kinase-Rho GTPase Signal Pathways and Cytoskeletal Rearrangements. J. Virol.
78: 4207-4223
[Abstract][Full Text]
SODHI, A., MONTANER, S., GUTKIND, J. S.
(2004). Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?. FASEB J.
18: 422-427
[Abstract][Full Text]
Naranatt, P. P., Krishnan, H. H., Svojanovsky, S. R., Bloomer, C., Mathur, S., Chandran, B.
(2004). Host Gene Induction and Transcriptional Reprogramming in Kaposi's Sarcoma-Associated Herpesvirus (KSHV/HHV-8)-Infected Endothelial, Fibroblast, and B Cells: Insights into Modulation Events Early during Infection. Cancer Res.
64: 72-84
[Abstract][Full Text]
Cool, C. D., Rai, P. R., Yeager, M. E., Hernandez-Saavedra, D., Serls, A. E., Bull, T. M., Geraci, M. W., Brown, K. K., Routes, J. M., Tuder, R. M., Voelkel, N. F.
(2003). Expression of Human Herpesvirus 8 in Primary Pulmonary Hypertension. NEJM
349: 1113-1122
[Abstract][Full Text]
Rosano, L., Spinella, F., Di Castro, V., Nicotra, M. R., Albini, A., Natali, P. G., Bagnato, A.
(2003). Endothelin Receptor Blockade Inhibits Molecular Effectors of Kaposi's Sarcoma Cell Invasion and Tumor Growth in Vivo. Am. J. Pathol.
163: 753-762
[Abstract][Full Text]
Akula, S. M., Naranatt, P. P., Walia, N.-S., Wang, F.-Z., Fegley, B., Chandran, B.
(2003). Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Infection of Human Fibroblast Cells Occurs through Endocytosis. J. Virol.
77: 7978-7990
[Abstract][Full Text]
Whitby, D., Stossel, A., Gamache, C., Papin, J., Bosch, M., Smith, A., Kedes, D. H., White, G., Kennedy, R., Dittmer, D. P.
(2003). Novel Kaposi's Sarcoma-Associated Herpesvirus Homolog in Baboons. J. Virol.
77: 8159-8165
[Abstract][Full Text]
Lundquist, A., Barre, B., Bienvenu, F., Hermann, J., Avril, S., Coqueret, O.
(2003). Kaposi sarcoma-associated viral cyclin K overrides cell growth inhibition mediated by oncostatin M through STAT3 inhibition. Blood
101: 4070-4077
[Abstract][Full Text]
Dittmer, D. P.
(2003). Transcription Profile of Kaposi's Sarcoma-associated Herpesvirus in Primary Kaposi's Sarcoma Lesions as Determined by Real-Time PCR Arrays. Cancer Res.
63: 2010-2015
[Abstract][Full Text]
Spiller, O. B., Blackbourn, D. J., Mark, L., Proctor, D. G., Blom, A. M.
(2003). Functional Activity of the Complement Regulator Encoded by Kaposi's Sarcoma-associated Herpesvirus. J. Biol. Chem.
278: 9283-9289
[Abstract][Full Text]
Wang, F.-Z., Akula, S. M., Sharma-Walia, N., Zeng, L., Chandran, B.
(2003). Human Herpesvirus 8 Envelope Glycoprotein B Mediates Cell Adhesion via Its RGD Sequence. J. Virol.
77: 3131-3147
[Abstract][Full Text]
Naranatt, P. P., Akula, S. M., Zien, C. A., Krishnan, H. H., Chandran, B.
(2002). Kaposi's Sarcoma-Associated Herpesvirus Induces the Phosphatidylinositol 3-Kinase-PKC-{zeta}-MEK-ERK Signaling Pathway in Target Cells Early during Infection: Implications for Infectivity. J. Virol.
77: 1524-1539
[Abstract][Full Text]
Bowser, B. S., DeWire, S. M., Damania, B.
(2002). Transcriptional Regulation of the K1 Gene Product of Kaposi's Sarcoma-Associated Herpesvirus. J. Virol.
76: 12574-12583
[Abstract][Full Text]
Ablashi, D. V., Chatlynne, L. G., Whitman, J. E. Jr., Cesarman, E.
(2002). Spectrum of Kaposi's Sarcoma-Associated Herpesvirus, or Human Herpesvirus 8, Diseases. Clin. Microbiol. Rev.
15: 439-464
[Abstract][Full Text]
Emond, J.-P., Marcelin, A.-G., Dorent, R., Milliancourt, C., Dupin, N., Frances, C., Agut, H., Gandjbakhch, I., Calvez, V.
(2002). Kaposi's Sarcoma Associated with Previous Human Herpesvirus 8 Infection in Heart Transplant Recipients. J. Clin. Microbiol.
40: 2217-2219
[Abstract][Full Text]
Fakhari, F. D., Dittmer, D. P.
(2002). Charting Latency Transcripts in Kaposi's Sarcoma-Associated Herpesvirus by Whole-Genome Real-Time Quantitative PCR. J. Virol.
76: 6213-6223
[Abstract][Full Text]
Fata, F., Mirza, A., Bernath, A.
(2002). Skin Lesions in Melanoma and Kaposi's Sarcoma: Case 3. Familial Classic Mediterranean Kaposi's Sarcoma. JCO
20: 1415-1418
[Full Text]
Schecter, W. P.
(2001). Human Immunodeficiency Virus and Malignancy: Thoughts on Viral Oncogenesis. Arch Surg
136: 1419-1425
[Full Text]
Davis, D. A., Rinderknecht, A. S., Zoeteweij, J. P., Aoki, Y., Read-Connole, E. L., Tosato, G., Blauvelt, A., Yarchoan, R.
(2001). Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus. Blood
97: 3244-3250
[Abstract][Full Text]
Moore, P. S.
(2000). The Emergence of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8). NEJM
343: 1411-1413
[Full Text]
Foster, C. B., Lehrnbecher, T., Samuels, S., Stein, S., Mol, F., Metcalf, J. A., Wyvill, K., Steinberg, S. M., Kovacs, J., Blauvelt, A., Yarchoan, R., Chanock, S. J.
(2000). An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. Blood
96: 2562-2567
[Abstract][Full Text]
Washenik, K., Clark-Loeser, L., Friedman-Kien, A., Simonart, T., Vooren, J.-P. V., Meuris, S., Mazzone, A., Ottini, E., Paulli, M., Antman, K., Chang, Y.
(2000). Kaposi's Sarcoma. NEJM
343: 581-584
[Full Text]